We are live on
!
Find out more
AI
Alphabet Inc Portfolio holdings
AUM
$4.02B
1-Year Est. Return
215.74%
This Fund
S&P 500
This Quarter
Est. Return
+16.04%
1 Year Est. Return
+215.74%
3 Year Est. Return
+350.01%
5 Year Est. Return
+242.03%
10 Year Est. Return
+998.87%
AUM
$4.02B
AUM Growth
+$1.44B
(+56%)
Cap. Flow
+$1.15B
Cap. Flow
% of AUM
28.6%
Top 10 Holdings %
Top 10 Hldgs %
94.04%
Holding
32
New
3
Increased
1
Reduced
3
Closed
6
Top Buys
| 1 |
CME Group
CME
|
+$1.03B |
| 2 |
Planet Labs
PL
|
+$84.5M |
| 3 |
PAYP
PayPay
PAYP
|
+$66.1M |
| 4 |
LIFE
Ethos Technologies Inc
LIFE
|
+$44.6M |
Top Sells
| 1 |
DexCom
DXCM
|
+$68.8M |
| 2 |
Revolution Medicines
RVMD
|
+$5.31M |
| 3 |
GeneDx Holdings
WGS
|
+$2.95M |
| 4 |
EXAS
Exact Sciences
EXAS
|
+$2.36M |
| 5 |
Monte Rosa Therapeutics
GLUE
|
+$1.16M |
Sector Composition
| 1 | Technology | 34.27% |
| 2 | Financials | 26.67% |
| 3 | Industrials | 24.53% |
| 4 | Healthcare | 14.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
CME Group
CME
$88.1B
| $1.03B | 25.63% |
+3,484,020
| New | +$1.03B |
|
|
2
Planet Labs
PL
$7.87B
| $985M | 24.53% |
35,248,893
+3,306,252
| +10% | +$84.5M |
|
3
AST SpaceMobile
ASTS
$16.2B
| $741M | 18.46% |
8,943,486
| – | – |
|
|
4
Revolution Medicines
RVMD
$38.1B
| $320M | 7.97% |
3,292,525
-52,577
| -2% | -$5.31M |
|
5
Arm
ARM
$271B
| $297M | 7.39% |
1,960,784
| – | – |
|
6
Freshworks
FRSH
$3B
| $130M | 3.24% |
16,206,643
| – | – |
|
7
UiPath
PATH
$6.16B
| $78.1M | 1.94% |
7,034,337
| – | – |
|
|
TEM
8
Tempus AI
TEM
$9.75B
| $70.1M | 1.75% |
1,551,102
| – | – |
|
|
PAYP
9
PayPay
PAYP
$10.5B
| $66.7M | 1.66% |
+3,125,000
| New | +$66.1M |
|
10
GitLab
GTLB
$5.33B
| $59M | 1.47% |
2,724,712
| – | – |
|
11
Prime Medicine
PRME
$587M
| $57.6M | 1.44% |
16,562,498
| – | – |
|
|
LIFE
12
Ethos Technologies Inc
LIFE
$1.18B
| $42.1M | 1.05% |
+3,770,156
| New | +$44.6M |
|
|
MAZE
13
Maze Therapeutics
MAZE
$1.54B
| $41.4M | 1.03% |
1,388,583
| – | – |
|
|
BBOT
14
BridgeBio Oncology
BBOT
$651M
| $25.3M | 0.63% |
2,823,126
| – | – |
|
15
Relay Therapeutics
RLAY
$4.19B
| $15.6M | 0.39% |
1,564,173
-4,580
| -0.3% | -$41K |
|
|
16
Monte Rosa Therapeutics
GLUE
$1.93B
| $11.3M | 0.28% |
684,275
-60,673
| -8% | -$1.16M |
|
17
Vera Therapeutics
VERA
$2.88B
| $9.71M | 0.24% |
241,264
| – | – |
|
18
Sana Biotechnology
SANA
$921M
| $8.1M | 0.2% |
2,812,500
| – | – |
|
19
Beam Therapeutics
BEAM
$2.93B
| $7.66M | 0.19% |
321,604
| – | – |
|
20
Lyell Immunopharma
LYEL
$338M
| $5.88M | 0.15% |
293,256
| – | – |
|
21
Oscar Health
OSCR
$8.85B
| $5.53M | 0.14% |
481,988
| – | – |
|
|
FIG
22
Figma
FIG
$12.2B
| $4.56M | 0.11% |
215,582
| – | – |
|
23
Spero Therapeutics
SPRO
$91.5M
| $2.08M | 0.05% |
889,979
| – | – |
|
24
Hyperfine
HYPR
$95.9M
| $971K | 0.02% |
898,720
| – | – |
|
|
AUTL
25
Autolus Therapeutics
AUTL
$397M
| $964K | 0.02% |
698,262
| – | – |
|
Similar funds
AT
JSW
CSP
BWA
MAM
GCM
USCWA
ICP